Cite

HARVARD Citation

    Volz, B. et al. (n.d.). Induction of tumor-specific immune responses by the TLR9 agonist EnanDIM in murine syngeneic tumor models. European journal of cancer. pp. S13-. [Online]. 
  
Back to record